M.A. Gross

822 total citations
21 papers, 687 citations indexed

About

M.A. Gross is a scholar working on Molecular Biology, Hematology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, M.A. Gross has authored 21 papers receiving a total of 687 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Hematology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in M.A. Gross's work include Hematopoietic Stem Cell Transplantation (5 papers), Microbial Natural Products and Biosynthesis (2 papers) and Inhalation and Respiratory Drug Delivery (2 papers). M.A. Gross is often cited by papers focused on Hematopoietic Stem Cell Transplantation (5 papers), Microbial Natural Products and Biosynthesis (2 papers) and Inhalation and Respiratory Drug Delivery (2 papers). M.A. Gross collaborates with scholars based in United States, Israel and Germany. M.A. Gross's co-authors include James R. Zucali, Roy S. Weiner, Lori Anderson, D J Oblon, Charles A. Dinarello, A. A. Yunis, Ming Wu, Jan S. Moreb, H E Broxmeyer and C A Dinarello and has published in prestigious journals such as Journal of Clinical Investigation, The Journal of Immunology and Biochemistry.

In The Last Decade

M.A. Gross

20 papers receiving 648 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M.A. Gross United States 12 306 184 156 139 57 21 687
Hans‐Peter Lohrmann Germany 10 323 1.1× 263 1.4× 99 0.6× 145 1.0× 52 0.9× 18 705
MT Esselink Netherlands 15 277 0.9× 145 0.8× 181 1.2× 176 1.3× 25 0.4× 34 689
Hsiu-san Lin United States 16 293 1.0× 142 0.8× 162 1.0× 192 1.4× 135 2.4× 29 827
M Möhler United States 11 252 0.8× 152 0.8× 218 1.4× 133 1.0× 89 1.6× 16 762
Z. Mishal France 13 331 1.1× 99 0.5× 171 1.1× 74 0.5× 106 1.9× 23 765
G Astaldi Netherlands 14 249 0.8× 139 0.8× 268 1.7× 55 0.4× 40 0.7× 75 761
P Miossec France 9 420 1.4× 110 0.6× 166 1.1× 120 0.9× 29 0.5× 15 788
T E Hugli United States 14 465 1.5× 148 0.8× 293 1.9× 91 0.7× 100 1.8× 17 913
Paula J.M. Vossebeld Netherlands 14 277 0.9× 216 1.2× 332 2.1× 218 1.6× 32 0.6× 16 849
Wayne Borcherding United States 13 237 0.8× 108 0.6× 313 2.0× 111 0.8× 34 0.6× 21 733

Countries citing papers authored by M.A. Gross

Since Specialization
Citations

This map shows the geographic impact of M.A. Gross's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.A. Gross with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.A. Gross more than expected).

Fields of papers citing papers by M.A. Gross

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M.A. Gross. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.A. Gross. The network helps show where M.A. Gross may publish in the future.

Co-authorship network of co-authors of M.A. Gross

This figure shows the co-authorship network connecting the top 25 collaborators of M.A. Gross. A scholar is included among the top collaborators of M.A. Gross based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M.A. Gross. M.A. Gross is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fauerbach, Loretta, et al.. (2006). Risk Factors for Meningitis Following Cerebral Angiography: A Case-Control Study. American Journal of Infection Control. 34(5). E139–E140.
2.
Fauerbach, Loretta, et al.. (2005). The quest for the irreducible minimum: 8 years of performance improvement in preventing central line–associated infections in a surgical intensive care unit. American Journal of Infection Control. 33(5). e60–e61. 2 indexed citations
3.
Lynch, James W., Gerald J. Elfenbein, Ward D. Noyes, et al.. (1994). Pure red cell aplasia associated with angioimmunoblastic lymphadenopathy with dysproteinemia. American Journal of Hematology. 46(2). 72–78. 9 indexed citations
4.
Moreb, Jan S., et al.. (1992). Role of aldehyde dehydrogenase in the protection of hematopoietic progenitor cells from 4-hydroperoxycyclophosphamide by interleukin 1 beta and tumor necrosis factor.. PubMed. 52(7). 1770–4. 37 indexed citations
5.
Moreb, Jan S., James R. Zucali, M.A. Gross, & Roy S. Weiner. (1989). Protective effects of IL-1 on human hematopoietic progenitor cells treated in vitro with 4-hydroperoxycyclophosphamide.. The Journal of Immunology. 142(6). 1937–1942. 31 indexed citations
6.
Gross, M.A., et al.. (1989). Local skin burn causes systemic (lung and kidney) endothelial cell injury reflected by increased circulating and decreased tissue factor VIII-related antigen.. PubMed. 106(2). 310–6; discussion 316. 12 indexed citations
7.
Zucali, James R., H E Broxmeyer, M.A. Gross, & C A Dinarello. (1988). Recombinant human tumor necrosis factors alpha and beta stimulate fibroblasts to produce hemopoietic growth factors in vitro.. The Journal of Immunology. 140(3). 840–844. 56 indexed citations
8.
Zucali, James R., Charles A. Dinarello, D J Oblon, et al.. (1986). Interleukin 1 stimulates fibroblasts to produce granulocyte-macrophage colony-stimulating activity and prostaglandin E2.. Journal of Clinical Investigation. 77(6). 1857–1863. 378 indexed citations
9.
Miller, AM, M.A. Gross, & A. A. Yunis. (1980). Heterogeneity of human colony-forming cells (CFUc) with respect to their sensitivity to chloramphenicol.. PubMed. 8(3). 236–42. 4 indexed citations
10.
Miller, AM, Grace K. Arimura, M.A. Gross, & A. A. Yunis. (1978). In vitro evidence for genetically determined variations in marrow erythroid cell sensitivity to chloramphenicol.. PubMed. 6(5). 455–60. 5 indexed citations
11.
Fojo, S S, Ming Wu, M.A. Gross, Yvonne Purcell, & A. A. Yunis. (1978). Purification and characterization of a colony stimulating factor from human lung. Biochemistry. 17(15). 3109–3116. 33 indexed citations
12.
Miller, Alan M., M.A. Gross, & A. A. Yunis. (1978). Heterogeneity of human colony-forming cells (CFU-C): differences in size, rate of colony formation, and responsiveness to colony-stimulating factor.. PubMed. 92(1). 38–44. 20 indexed citations
13.
Yunis, Adel A., Grace K. Arimura, Ming‐Chi Wu, M.A. Gross, & Yvonne Purcell. (1978). Purification of a colony stimulating factor from culture cell lines propagated from human lung. FEBS Letters. 90(2). 279–282. 9 indexed citations
14.
Fojo, S S, Ming Wu, M.A. Gross, & A. A. Yunis. (1977). The isolation and characterization of a colony stimulating factor from human lung. Biochimica et Biophysica Acta (BBA) - Protein Structure. 494(1). 92–99. 22 indexed citations
15.
Yunis, Adel A. & M.A. Gross. (1975). Drug-induced inhibition of myeloid colony growth: protective effect of colony-stimulating factor.. PubMed. 86(3). 499–504. 16 indexed citations
16.
Yunis, Adel A., et al.. (1975). Characteristics of rat carcinoma in culture.. PubMed. 35(2). 337–45. 16 indexed citations
17.
Wu, Ming, D. R. Schultz, Grace K. Arimura, M.A. Gross, & A. A. Yunis. (1975). Characteristics of fibrinolysin secreted by cultured rat breast carcinoma cells. Experimental Cell Research. 96(1). 37–46. 15 indexed citations
18.
Gross, M.A., et al.. (1970). Biosynthesis of zymonic acid in trichosporon capitatum. Journal of the Chemical Society D Chemical Communications. 73–73. 3 indexed citations
19.
Gross, M.A., et al.. (1970). Identity of “zymonic acid” with a pyruvate derivative. Journal of the Chemical Society D Chemical Communications. 0(16). 1030a–1030a. 3 indexed citations
20.
Gross, M.A., et al.. (1969). Hepatic Lipidosis Associated with l-Asparaginase Treatment. Experimental Biology and Medicine. 130(3). 733–736. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026